Efficacy of ivermectin pour-on against Ostertagia ostertagi infection and residues in the American bison, Bison bison.
Sixteen American bison, Bison bison, were artificially infected with 10(5) infective stage larvae of Ostertagia ostertagi on 21 April 1993. At 42 days post-infection eight bison were treated with 0.5% ivermectin pour-on (500 micrograms/kg bodyweight) and eight treated with the carrier only. Bison were necropsied 17 and 18 days post-treatment (21 and 22 June 1993, respectively). Mean (+/- SE) of 5,413 (+/- 1,716) adults and 565 (+/- 305) immature O. ostertagi were recovered at necropsy from bison treated with the carrier. No O. ostertagi were detected in bison treated with ivermectin pour-on. Based on the levels of the ivermectin marker metabolite in liver and adipose tissue 18 days post-treatment, the established bovine withdrawal time of 48 days appears adequate to insure that violative residues do not occur.
Marley
S E
SE
Centers for Disease Control & Prevention, Parasitic Diseases Division, Atlanta, Georgia 30341, USA.
Knapp
S E
SE
Rognlie
M C
MC
Thompson
J R
JR
Stoppa
T M
TM
Button
S M
SM
Wetzlich
S
S
Arndt
T
T
Craigmill
A
A
D000273:Adipose Tissue / Q000737:chemistry; D000287:Administration, Topical; D000818:Animals; D000969:Antinematodal Agents / Q000008:administration & dosage / Q000032:analysis / Q000627:therapeutic use*; D016164:Bison / Q000469:parasitology*; D004350:Drug Residues / Q000032:analysis; D005243:Feces / Q000469:parasitology; D005260:Female; D007559:Ivermectin / Q000008:administration & dosage / Q000032:analysis / Q000627:therapeutic use*; D008099:Liver / Q000737:chemistry; D010029:Ostertagiasis / Q000188:drug therapy / Q000662:veterinary*; D010270:Parasite Egg Count / Q000662:veterinary; D010865:Pilot Projects; D011897:Random Allocation
D000969:Antinematodal Agents; D007559:Ivermectin